Targeting Protein Degradation 4

Targeting protein degradation 4

Targeting protein degradation 4. Join SCI and receive discounts on this event and all future events.

SCI's Fine Chemicals Group and RSC's Biological and Medicinal Chemistry Sector.

Targeted Protein Degradation is one of the most promising therapeutic modalities that has emerged in the 21st Century. The Targeted Protein Degradation Market was worth USD 400.5 Million in 2021 and is expected to grow to USD 507.0 Million by 2022 and USD 3,300.0,000,000 by 2030. This has drawn interest from the academia, CROs, small and large pharma, and non-profit organizations.

This multidisciplinary conference aims to showcase the latest developments on design, biology and chemistry in TPD, within the themes of PROTACS, Molecular Glues, and non-PROTAC Degraders. We will highlight the latest in enabling technologies, such as Direct to Biology, HT Synthesis (click, Photochemistry, etc.) and structural biological methods.

The conference themes are open to submissions of oral or poster presentations. Abstracts of maximum 300 words should include title, authors, institutions, and the preference for presentation (Oral presentation or Poster). They can be sent to [email protected] under the subject "Targeting protein degradation 2024 - Abstract Submission". The number of presentation slots is limited. They will be distributed to ensure a balanced program. The best poster and presentation will receive prizes. Download the abstract template here.